In Vivo Engineering of Organs: the Bone Bioreactor
Molly M. Stevens, Robert P. Marin, Dirk Schaefer, Joshua Aronson, Robert Langer, and V. Prasad Shastri
It has long been the goal of tissue engineers to successfully utilize cells to create new tissues and organs so that they may be transplanted into patients in need. Over the years, some level of success has been achieved in simpler human tissues such as blood vessels and skin. It has proved to be harder to engineer organs and tissues with greater complexity, namely tissues with blood vessels running through them, such as bone tissue. Even if the tissue is cultured, the tissue needs to be successfully transplanted into the patient. At this point issues such as immune rejection and mechanically mismatched tissues need to be considered. To avoid such issues in culturing/transplanting bone tissue, this experiment focuses on exploring the regenerative properties of the bone’s periosteum cells to create an in-vivo bone bioreactor.
Periosteum cells are cells lining our bones that divide and differentiate upon wounding and fracture. It is hypothesized that the same healing response can be used to generate new tissue. To test this hypothesis, a saline solution was injected between the tibia and periosteum of rabbits. This was done to create a cavity that serves as a bioreactor for bone cells to grow. Alginate, a calcium-rich gel (which promotes bone cell formation), is then injected into this cavity to prevent it from collapsing when the saline solution is absorbed back into the body. Under these conditions, bone cells are allowed to grow and proliferate in this cavity over a period of a few weeks. The content (percentage of gel, percentage of saline, percentage of bone matrix) of the cavity is measured every week and data is compiled.
As predicted, within a few weeks, the cavities were filled with bone. The concentration of alginate gel and saline decreased over time as bone cells proliferated and filled up the cavities. By four weeks, more than 90% of the cavity was filled with new bone. This bone tissue was then removed and transplanted into damaged bone cites (defect was created in the rabbit’s bone) in the rabbit and the wounds healed seamlessly. As the transplantation was autologus, no immune rejection was observed. This result demonstrates not only the successful culturing of bone cells, but also the successful transplantation of bone tissue into a host with damaged bone. In conclusion, by utilizing this method of in-vivo bone regeneration, one can achieve desired periosteum differentiation and successful transplantation of new bone cells to other damaged bone cites within the same animal. Further research may allow for this method to benefit human patients with bone / spinal damage.
Not only was the hypothesis proven in this experiment, the methods utilized are clear and reproducible. The next step would be to conduct this experiment on human subjects. If this is successful, clinical applications would include fusing vertebrae in spinal fusions, bone repair for fractures/breakages, and cartilage replacement for arthritis. In addition, this process is much better than the current method of harvesting bone from a patient’s hip, which is very painful. Further research must be conducted to achieve this goal for humans, but the successful culturing/transplantation in rabbits has made this endeavor optimistic.